These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16941422)

  • 1. [Preventive treatment with topiramate enhances the quality of life of patients with migraine].
    Medrano V; Sempere AP; Morera-Guitart J; Fernandez-Izquierdo S; Espinosa-Martinez J
    Rev Neurol; 2006 Sep 1-15; 43(5):259-63. PubMed ID: 16941422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate as an adjunctive treatment in migraine prophylaxis.
    Martínez HR; Londoño O; Cantú-Martínez L; del Carmen Tarín L; Castillo CD
    Headache; 2003; 43(10):1080-4. PubMed ID: 14629243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topiramate or flunarizine in the preventive treatment of migraine. A comparative study of two series of cases].
    Gracia-Naya M; Latorre-Jiménez AM
    Rev Neurol; 2005 Dec 16-31; 41(12):705-8. PubMed ID: 16355353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topiramate in comorbid disorders: epilepsy and migraine].
    Dorado R; Gómez-Arguelles JM; Herrera A; Aragón E; Blanco M; Gilo-Arrojo F; Sepúlveda-Sánchez JM; González de la Aleja J; Anciones B
    Rev Neurol; 2006 Aug 16-31; 43(4):193-6. PubMed ID: 16883506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].
    Gracia-Naya M; Santos-Lasaosa S; Ríos-Gómez C; Sánchez-Valiente S; García-Gomara MJ; Latorre-Jiménez AM; Artal-Roy J; Mauri-Llerda JA
    Rev Neurol; 2011 Aug; 53(4):201-8. PubMed ID: 21780072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topiramate in the preventive treatment of migraine: experience in a tertiary center].
    Krymchantowski AV; Tavares C; Penteado Jd Jde C; Adriano M
    Arq Neuropsiquiatr; 2004 Mar; 62(1):91-5. PubMed ID: 15122440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.
    Nelles G; Schmitt L; Humbert T; Becker V; Sandow P; Bornhoevd K; Fritzsche D; Schäuble B;
    J Headache Pain; 2010 Feb; 11(1):33-44. PubMed ID: 19894100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain.
    Pascual J; Sánchez del Rio M; Mateos V; Láinez JM; Hernández-Gallego J; Leira R; Jiménez MD
    Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical use of topiramate for migraine prevention.
    Brandes JL
    Headache; 2005 Apr; 45 Suppl 1():S66-73. PubMed ID: 15833092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of migraine prevention: the case of topiramate in the UK.
    Brown JS; Papadopoulos G; Neumann PJ; Price M; Friedman M; Menzin J
    Cephalalgia; 2006 Dec; 26(12):1473-82. PubMed ID: 17116098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of topiramate in the prevention of childhood headaches.
    Hershey AD; Powers SW; Vockell AL; LeCates S; Kabbouche M
    Headache; 2002 Sep; 42(8):810-8. PubMed ID: 12390646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis.
    Von Seggern RL; Mannix LK; Adelman JU
    Headache; 2002 Sep; 42(8):804-9. PubMed ID: 12390645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate for migraine prevention: a randomized controlled trial.
    Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
    JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
    Brown JS; Rupnow MF; Neumann P; Friedman M; Menzin J
    Manag Care Interface; 2006 Dec; 19(12):31-8. PubMed ID: 17274479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.